Accelerating Next Generation Cell Medicine
Digital Technology Makes
Regenerative Medicine an Accessible Option
By providing a cell manufacturing platform using the latest digital technology,
and provide them to patients with high quality and affordable prices.
Our Strengths
Issue
We believe that there needs to be a way for anyone to efficiently manufacture high quality cellular products easily and seamlessly transition from one phase to another.
Solution
We provide a cell information data infrastructure that can be easily operated. Furthermore, we will develop products that can be utilized in the manufacturing phase.
Issue
We believe that there needs to be a way for anyone to efficiently manufacture high quality cellular products easily and seamlessly transition from one phase to another.
Solution
We provide a cell information data infrastructure that can be easily operated. Furthermore, we will develop products that can be utilized in the manufacturing phase.
NEWS
-
NEWS
10/24/2024
The results of joint development with Fancl:
“Development of AI technology to estimate protein expression levels in living cells”.
→Click here for FANCL’s release - Exhibition 10/09/2024- Exhibited at Japan Healthcare Venture Summit 2023
- Thesis 07/31/2024 Joint research with Fancl was published in Bioengineering.
- Exhibition 06/26/2024 Exhibited at the booth of Inabata Sangyo K.K. at the 26th Interphex Japan.
-
Exhibition
03/20/2024-
Corporate exhibition at the 23rd Annual Meeting
of the Japanese Society for Regenerative Medicine. - Speaking at Events 03/19/2024 Seminar Series on Sharing Challenges in Regenerative Medicine and Cell Therapy
- Exhibition 10/11/2023- Exhibited at Japan Healthcare Venture Summit 2023
-
Conference
03/23/2023
A quality evaluation system that can nondestructively determine cell adhesion ability
in the manufacturing process was developed and presented
at the 22nd Annual Meeting of the Japanese Society for Regenerative Medicine. - Speaking at Events 02/17/2023 TOP Runners in the Regenerative Medicine Industry at RINK FESTIVAL 2023.
- NEWS 12/16/2022 Announces New Management Structure
- Exhibition 10/12/2022- Exhibited at BioJapan2022 held at Pacifico Yokohama.
-
New Product
09/30/2022
We have released a complete lineup of cell monitoring devices
for all scenes of regenerative medicine. -
Conference
09/03/2022
The results of joint research with Fancl were presented
at the Japan Society for Bioimaging Science meeting held from September 3. - News 08/30/2022 Notice of Completion of WTrademark Registration
- News 05/13/2022 The floor area was increased to 100m2 due to the expansion of the staff size.
-
New Product
03/29/2022
Developed a cell monitoring device specialized for cell production,
achieving the world’s highest housing efficiency. -
Conference
03/18/2022
A report on the introduction at Jikei University
was presented at the annual meeting of the Japanese Society for Regenerative Medicine. - New Product 02/17/2022 Smart Management of Frozen Inventory function is released.
- News 10/04/2021 Our company was featured in Toshiba’s on-demand media, Toshiba Clip.First Second
-
News
07/09/2021
Selected as a recipient of assistance
from the Ministry of Economy, Trade and Industry (METI) - Finance 06/30/2021 Raised funds as a seed round from Beyond Next Ventures No. 2 Fund.
- Finance 06/30/2021 Carve-out and fundraising from Toshiba Corporation.
- News 05/14/2021 We established our company.
About us
General information about us
Partners
Cytoronix is looking for people who can work together.
Let’s work together to achieve a society where high quality and affordability are provided to patients!